Poland· PL-100482996
Tingapla
A linagliptin product containing linagliptinum, registered in Poland by Sandoz Polska Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Linagliptin is registered in 17 of 19 countries.
Countries holding a registration under ATC A10BH05 (linagliptin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Linagliptin · ATC A10BH05
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of linagliptin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linagliptin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- IT Italy$2.52
- CH Switzerland$2.05
The record
At a glance
URPL (Poland)- Active substance
- Linagliptinum
- Manufacturer
- Sandoz Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A10BH05
- ATC class
- Linagliptin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991561260
- gtin05909991561246
- gtin05909991561253
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
373 interactions on record for linagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Linagliptin · interactions on record
373 records
- 3 severe
- 330 moderate
- 40 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Linagliptin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGLUNAVAMedochemie Ltd., Limassol
- SpainDONUMID 5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGLaboratorios Alter S.A.
- SwedenDrojarto 5 mg Filmdragerad tablettDemo S.A.
- SwitzerlandLinagliptin NOBEL 5mg, FilmtablettenNOBEL Pharma Schweiz AG
- NetherlandsLinagliptine Abdi 5 mg filmomhulde tablettenAbdi Farma GmbH
- FinlandLinagliptin AccordAccord Healthcare B.V.
- IrelandLinagliptin Accord 5 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- IcelandAnsfiedAdalvo Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ilinpru, Liamell
- Belgium · Linagliptin Eg, Linagliptin Eg (Eurogenerics) Nv
- Bulgaria · Linagliptin Accord, Глунава
- Cyprus · Glunava, Linagliptin Accord
- Czechia · Glunava, Jeligo
- Germany · Linagliptin Abdi
- Denmark · Linagliptin "pharmapath", Linagliptin Accord
- Estonia · Glunava, Linagliptin Accord
- Spain · Donumid, Ilinpru
- Finland · Linagliptin Accord, Linagliptin Advanz Pharma
- France · Linagliptine Zentiva
- United Kingdom (Northern Ireland) · Linagliptin, Linagliptin Altair Science
- Greece · Bottiar, Drojarto
- Croatia · Larida, Liglinra
- Hungary · Ilinpru, Jeligo
- Ireland · Linagliptin Accord, Linagliptin Clonmel
- Iceland · Linagliptin Krka, Linagliptin Stada
- Italy · Linagliptin Abdi, Linagliptin Aurobindo
- Liechtenstein · Trajenta
- Lithuania · Bottiar, Jeligo
- Luxembourg · Linagliptin Eg
- Latvia · Linagliptin Accord, Linagliptin Olpha
- Malta · Liamell, Linagliptin
- Netherlands · Linagliptin Viatris, Linagliptin Vivanta
- Norway · Linagliptin Accord, Linagliptin Krka
- Portugal · Enanta, Larida
- Romania · Jeligo, Linagliptin Medochemie
- Sweden · Liglinra, Linagliptin Accord
- Slovenia · Liglipex, Linagliptin Krka
- Slovakia · Glunava, Ilinpru
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c986ebba-e40d-4826-9cd5-f41dabfb0a02 GET /v1/drugs/c986ebba-e40d-4826-9cd5-f41dabfb0a02?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909991561260 ¦ Rp ¦ 158782\n60 tabl.\n05909991561246 ¦ Rp ¦ 158783\n28 tabl.\n05909991561253 ¦ Rp ¦ 158784\n30 tabl.",
"substance": "Linagliptinum 5 mg",
"common_name": "Linagliptinum",
"pl_product_id": "100482996",
"pozwolenie_nr": "28769",
"auth_procedure": "DCP",
"authorisation_validity": "2029-12-18"
}See everything about linagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.